alpha -Synucleinopathy and selective dopaminergic neuron loss in a rat lentiviral-based model of Parkinson's disease
- PMID: 12122208
- PMCID: PMC125054
- DOI: 10.1073/pnas.152339799
alpha -Synucleinopathy and selective dopaminergic neuron loss in a rat lentiviral-based model of Parkinson's disease
Abstract
Parkinson's disease (PD) is characterized by the progressive loss of substantia nigra dopaminergic neurons and the presence of cytoplasmic inclusions named Lewy bodies. Two missense mutations of the alpha-synuclein (alpha-syn; A30P and A53T) have been described in several families with an autosomal dominant form of PD. alpha-Syn also constitutes one of the main components of Lewy bodies in sporadic cases of PD. To develop an animal model of PD, lentiviral vectors expressing different human or rat forms of alpha-syn were injected into the substantia nigra of rats. In contrast to transgenic mice models, a selective loss of nigral dopaminergic neurons associated with a dopaminergic denervation of the striatum was observed in animals expressing either wild-type or mutant forms of human alpha-syn. This neuronal degeneration correlates with the appearance of abundant alpha-syn-positive inclusions and extensive neuritic pathology detected with both alpha-syn and silver staining. Lentiviral-mediated expression of wild-type or mutated forms of human alpha-syn recapitulates the essential neuropathological features of PD. Rat alpha-syn similarly leads to protein aggregation but without cell loss, suggesting that inclusions are not the primary cause of cell degeneration in PD. Viral-mediated genetic models may contribute to elucidate the mechanism of alpha-syn-induced cell death and allow the screening of candidate therapeutic molecules.
Figures





Similar articles
-
Overexpression of alpha-synuclein in rat substantia nigra results in loss of dopaminergic neurons, phosphorylation of alpha-synuclein and activation of caspase-9: resemblance to pathogenetic changes in Parkinson's disease.J Neurochem. 2004 Oct;91(2):451-61. doi: 10.1111/j.1471-4159.2004.02728.x. J Neurochem. 2004. PMID: 15447678
-
Lentiviral nigral delivery of GDNF does not prevent neurodegeneration in a genetic rat model of Parkinson's disease.Neurobiol Dis. 2004 Nov;17(2):283-9. doi: 10.1016/j.nbd.2004.06.008. Neurobiol Dis. 2004. PMID: 15474365
-
A Drosophila model of Parkinson's disease.Nature. 2000 Mar 23;404(6776):394-8. doi: 10.1038/35006074. Nature. 2000. PMID: 10746727
-
Synucleins and their relationship to Parkinson's disease.Cell Tissue Res. 2004 Oct;318(1):163-74. doi: 10.1007/s00441-004-0921-7. Epub 2004 Jul 24. Cell Tissue Res. 2004. PMID: 15503152 Review.
-
Controversy: is Parkinson's disease a single disease entity? Yes.Parkinsonism Relat Disord. 2005 Jun;11 Suppl 1:S31-7. doi: 10.1016/j.parkreldis.2005.02.011. Epub 2005 Apr 20. Parkinsonism Relat Disord. 2005. PMID: 15885626 Review.
Cited by
-
DOPAnization of tyrosine in α-synuclein by tyrosine hydroxylase leads to the formation of oligomers.Nat Commun. 2022 Nov 12;13(1):6880. doi: 10.1038/s41467-022-34555-4. Nat Commun. 2022. PMID: 36371400 Free PMC article.
-
Immunohistochemical Study of Human Mitochondrial Ferritin in the Substantia Nigra Following Subarachnoid Hemorrhage.Acta Histochem Cytochem. 2024 Jun 28;57(3):101-108. doi: 10.1267/ahc.24-00002. Epub 2024 May 10. Acta Histochem Cytochem. 2024. PMID: 38988693 Free PMC article.
-
Dopaminergic neurodegeneration induced by Parkinson's disease-linked G2019S LRRK2 is dependent on kinase and GTPase activity.Proc Natl Acad Sci U S A. 2020 Jul 21;117(29):17296-17307. doi: 10.1073/pnas.1922184117. Epub 2020 Jul 6. Proc Natl Acad Sci U S A. 2020. PMID: 32631998 Free PMC article.
-
GDNF-based therapies, GDNF-producing interneurons, and trophic support of the dopaminergic nigrostriatal pathway. Implications for Parkinson's disease.Front Neuroanat. 2015 Feb 13;9:10. doi: 10.3389/fnana.2015.00010. eCollection 2015. Front Neuroanat. 2015. PMID: 25762899 Free PMC article. Review.
-
Mechanisms of alpha-synuclein action on neurotransmission: cell-autonomous and non-cell autonomous role.Biomolecules. 2015 May 13;5(2):865-92. doi: 10.3390/biom5020865. Biomolecules. 2015. PMID: 25985082 Free PMC article. Review.
References
-
- Polymeropoulos M. H., Lavedan, C., Leroy, E., Ide, S. E., Dehejia, A., Dutra, A., Pike, B., Root, H., Rubenstein, J., Boyer, R., et al. (1997) Science 276, 2045-2047. - PubMed
-
- Kruger R., Kuhn, W., Muller, T., Woitalla, D., Graeber, M., Kosel, S., Przuntek, H., Epplen, J. T., Schols, L. & Riess, O. (1998) Nat. Genet. 18, 106-108. - PubMed
-
- Spillantini M. G., Schmidt, M. L., Lee, V. M., Trojanowski, J. Q., Jakes, R. & Goedert, M. (1997) Nature (London) 388, 839-840. - PubMed
-
- Iwai A., Masliah, E., Yoshimoto, M., Ge, N., Flanagan, L., de Silva, H. A., Kittel, A. & Saitoh, T. (1995) Neuron 14, 467-475. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Miscellaneous